Christopher H Hawkes

1 month ago | msard-journal.com | Ann Ming Yeh |Christopher H Hawkes |Gavin Giovannoni |C. VirginiaO’Hayer

Get full text accessLog in, subscribe or purchase for full access. References1. Papadopoulos, M.C. ∙ Bennett, J.L. ∙ Verkman, A.S.Treatment of neuromyelitis optica: state-of-the-art and emerging therapiesNature Reviews Neurology. 2014; 10:493-5062. Sato, D.K. ∙ Lana-Peixoto, M.A. ∙ Fujihara, K. ... Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: Evolution and current statusBrain pathol. 2013; 23:647-6603. De Seze, J. ∙ Kremer, L. ∙ Collongues, N.

1 month ago | msard-journal.com | Jeannette Lechner-Scott |E. Ann Yeh |Christopher H Hawkes |Gavin Giovannoni

Get full text accessLog in, subscribe or purchase for full access. References1. Thouvenot, E. ∙ Laplaud, D. ∙ Lebrun-Frenay, C. ... D-Lay MS Investigators. High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical TrialJAMA. 2025; 333:1413-1422 Apr 22PMID: 40063041; PMCID: PMC118945462. Butzkueven, H.